Homologous recombination deficiency (HRD) testing of high-grade serous carcinoma using cytological samples. [PDF]
Demmer I +4 more
europepmc +1 more source
Uterine serous carcinoma and germline genetic testing: patterns of referral, completion and pathogenic variant detection. [PDF]
Tostrud L +8 more
europepmc +1 more source
Inhibiting CXCR2 Remodels the Tumor Microenvironment and Blunts Tumor Progression and Dissemination of High-Grade Serous Carcinoma. [PDF]
Mikeska RG +11 more
europepmc +1 more source
Characterizing intra- and intertumor heterogeneity in ovarian high-grade serous carcinoma subtypes using single-cell and spatial transcriptomics. [PDF]
Li W +6 more
europepmc +1 more source
Serous borderline tumor progressing to low-grade serous carcinoma after 35 years: a case of extended latency with molecular evidence of clonal relationship. [PDF]
Towery EA +3 more
europepmc +1 more source
Overexpression of a subset of long intergenic noncoding RNAs in uterine serous carcinoma predicts poor prognosis. [PDF]
Zhang Y, Huang QY, Qin X, Ma LL, Ye H.
europepmc +1 more source
Definitive Radiotherapy in Serous Carcinoma of Unknown Primary With Isolated Nodal Disease: A Case Review. [PDF]
Uzoukwu N +3 more
europepmc +1 more source
Antibiotic-Refractory Fever with Pyelonephritis-like Features Revealing Occult Metastatic High-Grade Serous Carcinoma: Competing Causes of Fever and Diagnostic Stewardship. [PDF]
Huang WH +7 more
europepmc +1 more source
A pilot translational study of neoadjuvant fulvestrant plus abemaciclib in women with advanced low-grade serous carcinoma. [PDF]
Cobb LP +31 more
europepmc +1 more source
Schlafen 11 (SLFN11) And Tumor-Infiltrating Lymphocytes (TILs): Dual Predictive Biomarkers In Ovarian Serous Carcinoma. [PDF]
Michael SR +6 more
europepmc +1 more source

